Deep Track Capital, LP - Dec 31, 2024 SCHEDULE 13G/A Report for 4D Molecular Therapeutics Inc. Common Stock, par value $0.0001 per share (FDMT)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
4D Molecular Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol
FDMT
Shares outstanding
46.2M shares
Disclosed Ownership
610K shares
Ownership
1.32%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 08:40 AM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 1.32% 610K 0 610K /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 1.32% 610K 0 610K /s/ David Kroin David Kroin, Director
David Kroin 1.32% 610K 0 610K /s/ David Kroin David Kroin